Seema Panchal

Dec 19, 2023 | jmg.bmj.com | Seema Panchal |Radhika Mahajan |Navneet Aujla |Paul McKay

Objective The purpose of this study was to recontact individuals with clinically actionable test results identified through a retrospective research study and to provide a framework for laboratories to recontact patients. Methods Genetic testing was conducted on 2977 individuals originally referred for BRCA1 and BRCA2 hereditary breast and ovarian cancer testing that had a negative genetic test result.